Consider the complete picture of a therapy's efficacy

I am writing to add clarification to an article about dry eye that underreports the clinical efficacy and symptom improvement period for cyclosporine (CsA) ophthalmic emulsion 0.05% (Restasis, Allergan) ("Dry eye: what's in the pipeline?" by Joseph Mussoline, MD, Ophthalmology Times, March 15, 2004, Pages 18 to 19).